Comparison 2. Hormone therapy versus placebo in secondary prevention.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Death (all‐causes)	7	5445	Risk Ratio (M‐H, Random, 95% CI)	1.04 [0.87, 1.24]
2 Death (cardiovascular causes)	6	5259	Risk Ratio (M‐H, Random, 95% CI)	1.00 [0.78, 1.29]
3 Non‐fatal myocardial infarction	7	5359	Risk Ratio (M‐H, Random, 95% CI)	0.98 [0.81, 1.18]
4 Stroke	5	5172	Risk Ratio (M‐H, Random, 95% CI)	1.09 [0.89, 1.33]
5 Angina	3	3155	Risk Ratio (M‐H, Random, 95% CI)	0.91 [0.74, 1.12]
6 Venous thromboembolism	6	4399	Risk Ratio (M‐H, Random, 95% CI)	2.02 [1.13, 3.62]
7 Pulmonary embolism	3	3920	Risk Ratio (M‐H, Random, 95% CI)	2.48 [0.92, 6.70]
8 Revascularisation	3	3155	Risk Ratio (M‐H, Random, 95% CI)	0.98 [0.63, 1.53]